Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts
- PMID: 1717721
- PMCID: PMC250340
- DOI: 10.1128/JVI.65.11.6307-6311.1991
Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts
Abstract
Persistent revertants have been generated from NIH 3T3 cells transformed by an activated human Ha-ras gene after short-term gamma interferon treatment in the presence of the cardiac aminoglycoside ouabain. Normal fibroblastlike morphology and anchorage dependence are restored in revertants. Tumorigenicity in nude mice is abolished. The revertants continue to express high steady-state levels of the ras oncogene. Partial retransformation of reverted cells is induced after 5-azacytidine treatment or after infection with retrovirus vectors carrying the v-abl, v-fes, v-myc, or v-src oncogene. The revertants resist the transforming activities of the v-Ha-ras and v-mos oncogenes.
Similar articles
-
Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.Mol Cell Biol. 1987 Jun;7(6):2196-200. doi: 10.1128/mcb.7.6.2196-2200.1987. Mol Cell Biol. 1987. PMID: 2439904 Free PMC article.
-
Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.Cancer Res. 1991 Jan 1;51(1):324-30. Cancer Res. 1991. PMID: 1703037
-
Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes.Cell. 1987 Nov 6;51(3):357-69. doi: 10.1016/0092-8674(87)90632-5. Cell. 1987. PMID: 3664639
-
Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.J Cell Physiol. 1991 Nov;149(2):214-21. doi: 10.1002/jcp.1041490207. J Cell Physiol. 1991. PMID: 1748716
-
Instability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformed by v-Ki-ras.Br J Cancer. 1989 Aug;60(2):211-5. doi: 10.1038/bjc.1989.253. Br J Cancer. 1989. PMID: 2504267 Free PMC article.
Cited by
-
Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.Am J Pathol. 2007 Oct;171(4):1352-68. doi: 10.2353/ajpath.2007.070241. Epub 2007 Sep 6. Am J Pathol. 2007. PMID: 17823279 Free PMC article.
-
Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.Mol Cell Biochem. 1999 Apr;194(1-2):79-91. doi: 10.1023/a:1006913122261. Mol Cell Biochem. 1999. PMID: 10391127
-
Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione.Mol Cell Biol. 1993 Jul;13(7):4416-22. doi: 10.1128/mcb.13.7.4416-4422.1993. Mol Cell Biol. 1993. PMID: 8321241 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous